news

Shardul Amarchand Mangaldas & Co (SAM) has advised private equity major Advent International on the purchase of a 50.1 percent stake in India’s Suven Pharmaceuticals, with Cyril Amarchand Mangaldas (CAM) advising the sellers, the Jasti family.

According to Reuters, Advent is expected to make an additional open offer for up to 26 percent of the voting share capital held by public shareholders. Advent intends to explore merging Suven with its wholly owned Cohance Lifesciences to build a company that specializes in active pharmaceutical ingredients as well as contract development and manufacturing businesses, Reuters added.

 

The CAM team was led by partner Shishir Vayttaden, with support from partners Namrata Kolar, Biplab Lenin, and Avaantika Kakkar.

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Appointments

SAM hires white-collar specialist in Delhi

by Nimitt Dixit |

Shardul Amarchand Mangaldas & Co has added investigations expert Rohit Dhingra as a partner in its white-collar crime practice in Delhi. Dhingra was previously a managing director in the risk advisory and investigation practice at FTI Consulting.

Deals

SAM, CAM, Latham act on Ather Energy’s upcoming $536 mln IPO

by Nimitt Dixit |

Shardul Amarchand Mangaldas & Co is advising Indian electric two-wheeler maker Ather Energy on its upcoming $536.2 million initial public offering (45 billion rupees), as more emerging companies than ever before turn to India’s red-hot stock market to raise funds.

Deals

SAM, Trilegal, Touchstone, Links act on $336 mln Premier Energies IPO

by Nimitt Dixit |

India’s Shardul Amarchand Mangaldas has continued its strong IPO performance this year, advising Premier Energies on its $336 million listing. Trilegal and Linklaters represented the book-running lead managers, while Touchstone Partners acted for the selling shareholders in the offer for sale (OFS).